DBV Technologies S.A.
NASDAQ:DBVTBiotechnology
-$0.16 today
- Market cap
- $238.98M
- Beta
- -0.22
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$0.39
Volume 0.17M
Average 0.24M
Returns on capital
DBV Technologies S.A. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-87.1%
avg -103.7%
ROIC
-76.6%
avg -88.6%
ROA
-62.9%
avg -64.3%
Analysis
ROA is currently the strongest return metric at -62.9% versus its period average of -64.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Daniel Tassé | Chief Executive Officer & Director | USD 1.44M | 66 | 964.00K | 4.03% |
Pharis Mohideen | Chief Medical Officer | USD 1.02M | 61 | 144.53K | 0.60% |
Virginie Simone Jeanine Verrechia Boucinha | Chief Financial Officer | USD 600.14K | 57 | — | — |
Alan Kerr | Senior Vice President & Head of Global Regulatory Affairs | — | — | — | — |
Kevin Malobisky | Chief Operations Officer | — | — | — | — |
Robert G. Pietrusko D. | Chief Regulatory Officer | — | 78 | — | — |
James Briggs | Chief Human Resources Officer | — | 54 | — | — |
Jonathan Neely | VP & Head of Investor Relations | — | — | — | — |
Kevin Trapp | Chief Commercial Officer | — | 59 | — | — |
Pascal Wotling | Chief External Manufacturing & Supply Chain Officer | — | — | — | — |
Michele F. Robertson | Chief Legal Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 29, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
7
$15.51M
Net Transaction Value
−$15.51M
Net selling
Most Active
Mohideen Pharis
4 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Jul 29, 26Jul 29, 2026 | Mohideen Pharis Direct | Sell | $1.3K$1,252.80 |
| Jan 29, 26Jan 29, 2026 | Mohideen Pharis Direct | Sell | $2.6K$2,595.24 |
| Dec 18, 25Dec 18, 2025 | EPIC Bpifrance Indirect | Sell | $5.4M$5,413,911.57 |
| Dec 17, 25Dec 17, 2025 | EPIC Bpifrance Indirect | Sell | $9.9M$9,859,031.60 |
| Dec 17, 25Dec 17, 2025 | EPIC Bpifrance Indirect | Sell | $211.2K$211,200.00 |
| Nov 21, 25Nov 21, 2025 | Mohideen Pharis Direct | Sell | $4.5K$4,498.48 |
| Nov 20, 25Nov 20, 2025 | Mohideen Pharis Direct | Sell | $18.7K$18,708.48 |
Summary
Insiders reported 0 buys worth $0.00 and 7 sells worth $15.51M over the last 12 months. That adds up to net selling of $15.51M. Mohideen Pharis was the most active insider with 4 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Who does DBV Technologies S.A. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about DBVT's management, answered from reported figures.
Who manages DBVT?
DBV Technologies S.A. (DBVT) lists 11 active executives. The top listed executive is Alan Kerr, Senior Vice President & Head of Global Regulatory Affairs.
Are DBVT insiders buying or selling?
Recent insider activity shows net selling of $334,641.00.
Continue the stock analysis
Jump to another research area for this company.